![](/img/cover-not-exists.png)
Therapy for severe refractory acute graft-versus-host disease with basiliximab, a selective interleukin-2 receptor antagonist
Funke, V A M, de Medeiros, C R, Setúbal, D C, Ruiz, J, Bitencourt, M A, Bonfim, C M, Neto, J Z, Pasquini, RVolume:
37
Year:
2006
Language:
english
Pages:
5
DOI:
10.1038/sj.bmt.1705306
File:
PDF, 120 KB
english, 2006